Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Thomas F. Trahey"'
Autor:
Christopher M. O'Connor, Roderick B. Meese, Steven McNulty, Kathi D. Lucas, Robert J. Carney, Renee M. LeBoeuf, William Maddox, Charles F. Bethea, Neal Shadoff, Thomas F. Trahey, James A. Heinsimer, John M. Burks, Gerard O'Donnell, Mitchell W. Krucoff, Robert M. Califf, null The DUCCS-II Investigators
Publikováno v:
The American Journal of Cardiology. 77:791-797
The focus of new research efforts to improve the morbidity and mortality associated with acute myocardial infarction (AMI) has turned to adjuvant agents that show promise of improving outcomes following coronary thrombolysis. We enrolled 162 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b01012287998ba541d489ce7ebd310e4
https://doi.org/10.1016/s0002-9149(97)89171-0
https://doi.org/10.1016/s0002-9149(97)89171-0
Publikováno v:
Cancer Chemotherapy and Pharmacology. 13:176-180
The potential interaction of the antitumor agents vincristine and VP-16-213 was investigated in vivo. DBA/2 mice were inoculated with 10(6) P388 murine leukemia cells, after which single IP injections of saline only, vincristine only, VP-16-213 only,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40cc4e71d242ae65337942eacb5ee2f3
https://doi.org/10.1007/bf00269024
https://doi.org/10.1007/bf00269024
Autor:
Allen R. Chauvenet, Charles L. Spurr, James N. Atkins, Thomas F. Trahey, Don V. Jackson, Richard D. Callahan
Publikováno v:
Cancer chemotherapy and pharmacology. 14(1)
A phase II trial of prolonged IV infusions of vincristine was conducted in 21 patients with refractory acute leukemia. Patients received 0.25-0.50 mg/m2 by infusion daily for 5 days after an initial 0.5-mg bolus. A partial response was observed in on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29db3217b7cf020f338717ee7fc8548e
https://pubmed.ncbi.nlm.nih.gov/3965157
https://pubmed.ncbi.nlm.nih.gov/3965157